litlas
Log inCreate account

Frank Berthold

Active 1987–2023

91
Papers
21,112
Citations
75
h-index
90
i10-index

Citations

Citations per year for Frank Berthold1967: 1 citations1981: 1 citations1986: 2 citations1989: 3 citations1990: 5 citations1991: 6 citations1992: 7 citations1993: 12 citations1994: 14 citations1995: 20 citations1996: 18 citations1997: 34 citations1998: 22 citations1999: 31 citations2000: 54 citations2001: 51 citations2002: 113 citations2003: 167 citations2004: 166 citations2005: 188 citations2006: 174 citations2007: 151 citations2008: 198 citations2009: 159 citations2010: 239 citations2011: 208 citations2012: 155 citations2013: 182 citations2014: 186 citations2015: 199 citations2016: 198 citations2017: 255 citations2018: 209 citations2019: 622 citations2020: 649 citations2021: 543 citations2022: 401 citations2023: 268 citations2024: 359 citations2025: 174 citations2026: 8 citations1968–1980: no citations, so these years are not shown1982–1985: no citations, so these years are not shown1987–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,009 citing papers, 24.7% of this breakdownChina: 651 citing papers, 8% of this breakdownGermany: 644 citing papers, 7.9% of this breakdownUnited Kingdom: 519 citing papers, 6.4% of this breakdownItaly: 394 citing papers, 4.8% of this breakdownFrance: 318 citing papers, 3.9% of this breakdownCanada: 292 citing papers, 3.6% of this breakdownNetherlands: 265 citing papers, 3.3% of this breakdownJapan: 241 citing papers, 3% of this breakdownAustralia: 239 citing papers, 2.9% of this breakdownSpain: 215 citing papers, 2.6% of this breakdownIndia: 195 citing papers, 2.4% of this breakdown
0%24.7%Other 26.5%

Institutions

Fields

  • Medicine51.9%
  • Biochemistry, Genetics and Molecular Biology34.5%
  • Computer Science6.8%
  • Immunology and Microbiology1.7%
  • Engineering1.1%
  • Mathematics0.8%
  • Other3.2%

Topics

  • Neuroblastoma Research and Treatments10.9%
  • Gene expression and cancer classification7.6%
  • Cancer, Hypoxia, and Metabolism4.3%
  • Bioinformatics and Genomic Networks3.8%
  • Glioma Diagnosis and Treatment2.9%
  • Cancer therapeutics and mechanisms2.1%
  • Other68.4%

Coauthors

All papers

Open in search
  1. Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Authors: Navin Pinto, Mark A. Applebaum, Samuel L. Volchenboum, Katherine K. Matthay, Wendy B. London, Peter F. Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher, Julie R. Park, Dominique Valteau‐Couanet, Andrew D.J. Pearson, Susan L. Cohn - Journal of Clinical Oncology 2015 cited by 931

  2. Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

    Authors: Javed Khan, Jun S. Wei, Markus Ringnér, Lao H. Saal, Marc Ladanyi, Frank Westermann, Frank Berthold, Manfred Schwab, Cristina R. Antonescu, Carsten Peterson, Paul S. Meltzer - Nature Medicine 2001 cited by 2,662

  3. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models

    Authors: Brett T. Thorn, Zhichao Liu, Stephen Harris, Baitang Ning, Lei Xu, Lun Yang, Huixiao Hong, Jie Liu, Zhiguang Li, James C. Fuscoe, Leming Shi, Qiang Shi, Weigong Ge, Min Zhang, Minjun Chen, Roger Perkins, Zhining Wen, Weida Tong, Reena Philip, Uwe Scherf, Francisco Martínez-Murillo, Rong Tang, Gene Pennello, Brandon D. Gallas, Gregory Campbell, Lakshmi Vishnuvajjala, F. W. Samuelson, Živana Težak, Weijie Chen, Wendell Jones, Joel S. Parker, Fabien Campagne, Stephen J. Walker, Zhenqiang Su, Joshua Xu, Hong Fang, Feng Qian, Dhivya Arasappan, Zhenqiang Su, Russell D. Wolfinger, Padraic Neville, Tzu‐Ming Chu, Li Li, Wenjun Bao, Kelci Miclaus, Pei-Yi Tan, Wendy Czika, Federico Goodsaid, Mat Soukup, Li Zhang, Jialü Zhang, Sue Jane Wang, Lajos Pusztai, John D. Shaughnessy, Bart Barlogie, Yiming Zhou, Matthias Fischer, André Oberthuer, Yvonne Kahlert, Frank Berthold, Russell S. Thomas, J.-H Chou, Richard S. Paules, Jennifer Fostel, Pierre R. Bushel, Mark R. Fielden, Pan Du, Simon Lin, Cesare Furlanello, Giuseppe Jurman, Samantha Riccadonna, Roberto Visintainer, Xijin Ge, Dalila B. Megherbi, Manuel Madera, W. Fraser Symmans, May D. Wang, R. Mitchell Parry, Todd H. Stokes, John H. Phan, Andrea B. Moffitt, Jun Luo, John H. Zhang, Matthew Woods, Eric W. Wang, Hans Bitter, Dilafruz Juraeva, Benedikt Brors, Frank Westermann, Roland Eils, Johan Trygg, Max Bylesjö, Jie Cheng, Jing Cheng, Timothy S. Davison, Mauro Delorenzi, Vlad Popovici, Youping Deng, Viswanath Devanarayan, Richard Judson and 101 more - Nature Biotechnology 2010 cited by 915

  4. Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

    Authors: Julie R. Park, Rochelle Bagatell, Susan L. Cohn, Andrew D.J. Pearson, Judith G. Villablanca, Frank Berthold, Susan A. Burchill, Ariane Boubaker, Kieran McHugh, Jed G. Nuchtern, Wendy B. London, Nita L. Seibel, O. Wolf Lindwasser, John M. Maris, Penelope Brock, Gudrun Schleiermacher, Ruth Ladenstein, Katherine K. Matthay, Dominique Valteau‐Couanet - Journal of Clinical Oncology 2017 cited by 353

  5. A mechanistic classification of clinical phenotypes in neuroblastoma

    Authors: Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke, Ruth Volland, Roopika Menon, Johannes M. Heuckmann, Moritz Gartlgruber, Sabine Hartlieb, Kai‐Oliver Henrich, Konstantin Okonechnikov, Janine Altmüller, Peter Nürnberg, Steve Lefever, Bram De Wilde, Frederik Sand, Fakhera Ikram, Carolina Rosswog, J. Fischer, Jessica Theißen, Falk Hertwig, Aatur D. Singhi, Thorsten Simon, Wenzel Vogel, Sven Perner, Barbara Krug, Matthias Schmidt, Sven Rahmann, Viktor Achter, Ulrich Lang, Christian Vokuhl, Monika Ortmann, Reinhard Büttner, Angelika Eggert, Frank Speleman, Roderick J. O’Sullivan, Roman K. Thomas, Frank Berthold, Jo Vandesompele, Alexander Schramm, Frank Westermann, Johannes H. Schulte, Martin Peifer, Matthias Fischer - Science 2018 cited by 337

  6. Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

    Authors: Wenqian Zhang, Ying Yu, Falk Hertwig, Jean Thierry‐Mieg, Wenwei Zhang, Danielle Thierry‐Mieg, Jian Wang, Cesare Furlanello, Viswanath Devanarayan, Jie Cheng, Youping Deng, Barbara Hero, Huixiao Hong, Meiwen Jia, Li Li, Simon Lin, Yuri Nikolsky, André Oberthuer, Tao Qing, Zhenqiang Su, Ruth Volland, Charles Wang, May D. Wang, Junmei Ai, Davide Albanese, Shahab Asgharzadeh, Smadar Avigad, Wenjun Bao, Marina Bessarabova, Murray H. Brilliant, Benedikt Brors, Marco Chierici, Tzu‐Ming Chu, Jibin Zhang, Richard G. Grundy, Min He, Scott J. Hebbring, Howard L. Kaufman, Samir Lababidi, Lee Lancashire, Yan Li, Xin X. Lu, Heng Luo, Xiwen Ma, Baitang Ning, Rosa Noguera, Martin Peifer, John H. Phan, Frederik Roels, Carolina Rosswog, Susan Shao, Jie Shen, Jessica Theißen, Gian Paolo Tonini, Jo Vandesompele, Po-Yen Wu, Wenzhong Xiao, Joshua Xu, Weihong Xu, Jiekun Xuan, Yong Yang, Zhan Ye, Zirui Dong, Ke Zhang, Ye Yin, Chen Zhao, Yuanting Zheng, Russell D. Wolfinger, Tieliu Shi, Linda H. Malkas, Frank Berthold, Jun Wang, Weida Tong, Leming Shi, Zhiyu Peng, Matthias Fischer - Genome Biology 2015 cited by 429

  7. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

    Authors: G M Brodeur, Jon Pritchard, Frank Berthold, Niels Carlsen, Victoria Castel, R P Castelberry, Bruno De Bernardi, Audrey E. Evans, M Favrot, F Hedborg - Journal of Clinical Oncology 1993 cited by 2,315

  8. ecancermedicalscience

    Authors: Gauthier Bouche, Nicolás André, Shripad Banavali, Frank Berthold, Alfredo Berruti, Guido Bocci, Giovanni Brandi, Ugo Cavallaro, Saverio Cinieri, Marco Colleoni, Giuseppe Curigliano, Teresa Di Desidero, Alexandru Eniu, Nicola Fazio, Robert S. Kerbel, Lisa Hutchinson, Urszula Ledzewicz, Elisabetta Munzone, Eddy Pasquier, O. Graciela Scharovsky, Yuval Shaked, Jaroslav Štěrba, Martín Villalba, Francesco Bertolini - ecancermedicalscience 2016 cited by 679

  9. Telomerase activation by genomic rearrangements in high-risk neuroblastoma

    Authors: Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L. Roncaioli, Frederik Sand, Johannes M. Heuckmann, Fakhera Ikram, René Schmidt, Sandra Ackermann, Anne Engesser, Yvonne Kahlert, Wenzel Vogel, Janine Altmüller, Peter Nürnberg, Jean Thierry‐Mieg, Danielle Thierry‐Mieg, Aruljothi Mariappan, Stefanie Heynck, Erika Mariotti, Kai‐Oliver Henrich, Christian Johannes Gloeckner, Graziella Bosco, Ivo Leuschner, Michal R. Schweiger, Larissa Savelyeva, Simon C. Watkins, Chunxuan Shao, Emma Bell, Thomas Höfer, Viktor Achter, Ulrich Lang, Jessica Theißen, Ruth Volland, Maral Saadati, Angelika Eggert, Bram De Wilde, Frank Berthold, Zhiyu Peng, Chen Zhao, Leming Shi, Monika Ortmann, Reinhard Büttner, Sven Perner, Barbara Hero, Alexander Schramm, Johannes H. Schulte, Carl Herrmann, Roderick J. O’Sullivan, Frank Westermann, Roman K. Thomas, Matthias Fischer - Nature 2015 cited by 618

  10. Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastoma

    Authors: H Kocak, Sandra Ackermann, Barbara Hero, Yvonne Kahlert, André Oberthuer, Dilafruz Juraeva, Frederik Roels, Jessica Theißen, Frank Westermann, Hedwig E. Deubzer, Volker Ehemann, Benedikt Brors, Margarete Odenthal, Frank Berthold, Matthias Fischer - Cell Death and Disease 2013 cited by 233

  11. Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Authors: Wendy B. London, Victoria Castel, Tom Monclair, Peter F. Ambros, Andrew D.J. Pearson, Susan L. Cohn, Frank Berthold, Akira Nakagawara, Ruth Ladenstein, Tomoko Iehara, Katherine K. Matthay - Journal of Clinical Oncology 2011 cited by 330

  12. Genomic ALK alterations in primary and relapsed neuroblastoma

    Authors: Carolina Rosswog, Jana Fassunke, Angela Ernst, Birgid Schömig‐Markiefka, Sabine Merkelbach‐Bruse, Christoph Bartenhagen, Maria Cartolano, Sandra Ackermann, Jessica Theißen, Mirjam Blattner-Johnson, Barbara Jones, Kathrin Schramm, Janine Altmüller, Peter Nürnberg, Monika Ortmann, Frank Berthold, Martin Peifer, Reinhard Büttner, Frank Westermann, Johannes H. Schulte, Thorsten Simon, Barbara Hero, Matthias Fischer - British Journal of Cancer 2023 cited by 66

  13. Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma

    Authors: Shahab Asgharzadeh, Jill Salo, Lingyun Ji, André Oberthuer, Matthias Fischer, Frank Berthold, Michael D. Hadjidaniel, Cathy Wei-Yao Liu, Leonid S. Metelitsa, Roger Piqué-Regi, Peter Wakamatsu, Judith G. Villablanca, Susan G. Kreissman, Katherine K. Matthay, Hiroyuki Shimada, Wendy B. London, Richard Sposto, Robert C. Seeger - Journal of Clinical Oncology 2012 cited by 285

  14. Impact of RNA-seq data analysis algorithms on gene expression estimation and downstream prediction

    Authors: Tong Li, Po-Yen Wu, John H. Phan, Hamid R. Hassazadeh, Wendell Jones, Leming Shi, Matthias Fischer, Christopher E. Mason, Sheng Li, Joshua Xu, Wei Shi, Jian Wang, Jean Thierry‐Mieg, Danielle Thierry‐Mieg, Falk Hertwig, Frank Berthold, Barbara Hero, Yang Liao, Gordon K. Smyth, David P. Kreil, Paweł P. Łabaj, Dalila B. Megherbi, Gary P. Schroth, Hong Fang, Weida Tong, May D. Wang - Scientific Reports 2020 cited by 45

  15. Comparing presentations and outcomes of children with cancer: a study between a lower-middle-income country and a high-income country

    Authors: Ahmed Farrag, Mohamed Hamdy Ghazaly, Khaled Mohammed, Ruth Volland, Barbara Hero, Frank Berthold - BMC Pediatrics 2023 cited by 26

  16. Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial

    Authors: Frank Berthold, Joachim Boos, Stefan Burdach, R. Erttmann, Günter Henze, Johann Hermann, Thomas Klingebiel, Bernhard Kremens, Freimut H. Schilling, Martin Schrappe, Thorsten Simon, Barbara Hero - The Lancet Oncology 2005 cited by 398

  17. Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97

    Authors: Barbara Hero, Thorsten Simon, Ruediger Spitz, Karen Ernestus, Astrid Gnekow, Hans-Guenther Scheel-Walter, Dirk Schwabe, Freimut H. Schilling, G. Benz-Bohm, Frank Berthold - Journal of Clinical Oncology 2008 cited by 308

  18. Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group

    Authors: Susan A. Burchill, Klaus Beiske, Hiroyuki Shimada, Peter F. Ambros, Robert C. Seeger, Godelieve A.M. Tytgat, Penelope Brock, Michelle Haber, Julie R. Park, Frank Berthold - Cancer 2016 cited by 119

  19. Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma

    Authors: Matthias W�lfl, Achim A. Jungbluth, Federico Garrido, Teresa Cabrera, Sharon Meyen-Southard, R�diger Spitz, Karen Ernestus, Frank Berthold - Cancer Immunology Immunotherapy 2004 cited by 108

  20. 2017 GPOH Guidelines for Diagnosis and Treatment of Patients with Neuroblastic Tumors

    Authors: Thorsten Simon, Barbara Hero, Johannes H. Schulte, Hedwig E. Deubzer, Patrick Hundsdoerfer, Dietrich von Schweinitz, Jörg Fuchs, Matthias Schmidt, Vikas Prasad, B. Krug, Beate Timmermann, Ivo Leuschner, Matthias Fischer, Thor s ten Langer, Kathy Astrahantseff, Frank Berthold, Holger N. Lode, Angelika Eggert - Klinische Pädiatrie 2017 cited by 104

  21. Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

    Authors: André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, René Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, Robert C. Seeger, Miki Ohira, Akira Nakagawara, Paola Scaruffi, Gian Paolo Tonini, Isabelle Janoueix‐Lerosey, Olivier Delattre, Gudrun Schleiermacher, Jo Vandesompele, Frank Speleman, Rosa Noguera, Marta Piqueras, Jean Bénard, Alexander Valent, Smadar Avigad, Isaac Yaniv, Richard G. Grundy, Monika Ortmann, Chunxuan Shao, Manfred Schwab, Roland Eils, Thorsten Simon, Jessica Theißen, Frank Berthold, Frank Westermann, Benedikt Brors, Matthias Fischer - Clinical Cancer Research 2014 cited by 99

  22. The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project

    Authors: V. V. Moroz, David Machin, Barbara Hero, Ruth Ladenstein, Frank Berthold, Paige Kao, Yaa Obeng, Andrew D.J. Pearson, Susan L. Cohn, Wendy B. London - Pediatric Blood & Cancer 2020 cited by 65

  23. Neuroblastoma: biology and molecular and chromosomal pathology

    Authors: Manfred Schwab, Frank Westermann, Barbara Hero, Frank Berthold - The Lancet Oncology 2003 cited by 326

  24. Treatment and outcomes of patients with relapsed, high‐risk neuroblastoma: Results of German trials

    Authors: Thorsten Simon, Frank Berthold, Arndt Borkhardt, Bernhard Kremens, B. De Carolis, Barbara Hero - Pediatric Blood & Cancer 2010 cited by 136